Abstract 3369: Utility of ctDNA-based targeted methylation MRD assay for hematological malignancies
Year: 2023
Type: conference-abstract
Source: Cancer Research
Institutions: AstraZeneca (United States), AstraZeneca (United Kingdom)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4362592880
